"Since 2005, the number of clinical trials in India has ballooned to 1,600 studies involving over 150,000 research subjects. Health campaigners in India have mounted a vigorous campaign calling for stricter regulation of an industry that has seen over 2,000 research participants die between 2007 and 2013. ... India’s health minister recently reported to the Indian parliament that to date, less than twenty-five family members have received compensation from foreign drug companies for loss of life. Families received an average of about $3,000 per individual – a pittance."